Decrease in ΔΨ on transition from the oxidized to the reduced state. by Vitaly A. Selivanov (133548)

MMS induces an Aag-dependent decrease in motor function. by Jennifer A. Calvo (399096)

Number of years to achieve the goal (with a probability >0.8) for moderate and high transmission settings (acquired immunity is assumed to be present). by Klodeta Kura (6803723)

FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells. by Laura L. Stafman (6577184)

“…<p>(A) Following 24 hours of treatment with FTY720, the viability of HuH6 cells measured using the alamarBlue cell viability assay was significantly decreased (LD₅₀ = 8.4 μM, p ≤ 0.05). …”

The velocity contour in all sections of air cabin (0.51 m/s). by Renquan Tu (19556120)

PI+ CD3+ T cells decrease at day 14 after IR while PI+ CD3- cells decrease at all time points. by Jordan A. Gunning (18143970)

The number of relationships categorised as high, intermediate and low quality for the original and alternative dynamics for the three increase and six decrease speeds with very high partner selectivity (LPS = 0.99). by Tonko W. Zijlstra (10521607)

Decrease of cell viability and alterations of cell membrane permeability by infection with rotavirus isolates. by Carlos A. Guerrero (1264551)

Expression of LMW tropomyosin in Type 2 diabetes. by Stuart A. Savill (3129060)

Subjects:

Tropomyosin isoform expression in normal controls and patients with Type 2 diabetes. by Stuart A. Savill (3129060)

Subjects:

Primer Sequences. by Stuart A. Savill (3129060)

Subjects:

Expression of HMW tropomyosin in Type 2 diabetes. by Stuart A. Savill (3129060)

Subjects:

TPM1 and TPM4 expression in response to TNFα. by Stuart A. Savill (3129060)

Subjects:

TPM1 protein expression in response to inflammatory cytokines. by Stuart A. Savill (3129060)

Subjects:

TPM1 and TPM4 expression in response to IL-1α. by Stuart A. Savill (3129060)

Subjects:

TPM1 and TPM4 expression in response to TNFα. by Stuart A. Savill (3129060)

Subjects:

TPM1 and TPM4 expression in response to glucose and insulin. by Stuart A. Savill (3129060)

Subjects:

TPM1 and TPM4 expression in response to IL-1α. by Stuart A. Savill (3129060)

Subjects:

Repeat sampling of individuals with Type 2 diabetes. by Stuart A. Savill (3129060)

Subjects:

Small Molecule ErbB Inhibitors Decrease Proliferative Signaling and Promote Apoptosis in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia by Mary E. Irwin (293687)

“…This approach has improved clinical responses, but molecular remissions are seen in less than 50% of patients leaving few treatment options in the event of relapse. …”